Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity

被引:114
作者
Coca, S [1 ]
Perazella, MA [1 ]
机构
[1] Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06520 USA
关键词
acute renal failure; tenofovir; HIV; AIDS; antiviral therapy;
D O I
10.1097/00000441-200212000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug-induced renal failure is a relatively common event in patients infected with HIV. This group of patients receives a number of potentially nephrotoxic medications for a variety of illnesses. The acyclic nucleoside phosphonates cidofovir and adefovir are antivirals that possess significant nephrotoxicity. Interestingly, tenofovir disoproxil fumurate (DF) is structurally similar to these 2 agents, yet seems to be less nephrotoxic based on a few published studies in HIV patients with intact renal function. We present a case in which acute renal failure developed after therapy with tenofovir DF in a patient with HIV and stable chronic kidney disease.
引用
收藏
页码:342 / 344
页数:3
相关论文
共 13 条
[1]   Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults [J].
Barditch-Crovo, P ;
Deeks, SG ;
Collier, A ;
Safrin, S ;
Coakley, DF ;
Miller, M ;
Kearney, BP ;
Coleman, RL ;
Lamy, PD ;
Kahn, JO ;
McGowan, I ;
Lietman, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2733-2739
[2]   The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1 [J].
Cihlar, T ;
Lin, DC ;
Pritchard, JB ;
Fuller, MD ;
Mendel, DB ;
Sweet, DH .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :570-580
[3]   CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS [J].
CUNDY, KC ;
BARDITCHCROVO, P ;
WALKER, RE ;
COLLIER, AC ;
EBELING, D ;
TOOLE, J ;
JAFFE, HS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2401-2405
[4]  
FISHER E, 1999, 6 C RETR OPP INF 199
[5]  
Ho ES, 2000, J AM SOC NEPHROL, V11, P383, DOI 10.1681/ASN.V113383
[6]   Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS [J].
Lalezari, JP ;
Holland, GN ;
Kramer, F ;
McKinley, GF ;
Kemper, CA ;
Ives, DV ;
Nelson, R ;
Hardy, WD ;
Kuppermann, BD ;
Northfelt, DW ;
Youle, M ;
Johnson, M ;
Lewis, RA ;
Weinberg, DV ;
Simon, GL ;
Wolitz, RA ;
Ruby, AE ;
Stagg, RJ ;
Jaffe, HS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (04) :339-344
[7]   Cidofovir: A new therapy for cytomegalovirus retinitis [J].
Lalezari, JP .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 :S22-S26
[8]   Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis [J].
Lalezari, JP ;
Kuppermann, BD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 :S27-S31
[9]   Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial - A randomized, controlled trial [J].
Lewis, RA ;
Carr, LM ;
Doyle, K ;
Fainstein, V ;
Gross, R ;
OrengoNania, S ;
Samo, TC ;
Shigley, JW ;
Spencer, SS ;
Weinert, M ;
Dunn, JP ;
Bartlett, J ;
Becker, R ;
Feinberg, J ;
Jabs, DA ;
Johnson, DA ;
LaSalvia, S ;
Miller, T ;
Neisser, LG ;
Semba, RD ;
TayKearney, ML ;
Tucker, P ;
Barron, B ;
Jarrott, C ;
Peyman, G ;
Swenie, D ;
Friedman, AH ;
Ginsburg, R ;
Sacks, H ;
Severin, C ;
Teich, S ;
Wallach, F ;
Rescigno, R ;
Cowan, J ;
Horan, C ;
Kloser, P ;
Wanner, M ;
Friedberg, DN ;
Addessi, A ;
Chachoua, A ;
Dieterich, D ;
Hill, J ;
Hutt, R ;
Ligh, J ;
LorenzoLatkany, M ;
Pei, M ;
Powers, T ;
Scoppe, C ;
Weinberg, DV ;
Jampol, LM .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :264-+
[10]   Cidofovir-induced end-stage renal failure [J].
Meier, P ;
Dautheville-Guibal, S ;
Ronco, PM ;
Rossert, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (01) :148-149